期刊
CURRENT OPINION IN IMMUNOLOGY
卷 28, 期 -, 页码 1-5出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2013.12.007
关键词
-
类别
资金
- Health Research Board in Ireland [PhD/2000719]
- Science Foundation Ireland (SFI) [12/IA/1421]
- SFI Research Centre, Advanced Materials and BioEngineering Research (AMBER) [SFI/12/RC/2278]
- Science Foundation Ireland (SFI) [12/IA/1421] Funding Source: Science Foundation Ireland (SFI)
Alum, the most common adjuvant in non-living vaccines, has a record of successful use in human vaccination where it promotes antibody-mediated protective immunity. However, alum is a poor inducer of cellular immune responses. The mechanism underlying the selective, enhancement of humoral immunity is still not well understood. Here, to provide an insight into its mode of action, recent findings regarding innate immune responses induced by alum and their impact on adaptive immunity are described, with a particular emphasis on early recognition of alum, including NLRP3 and PI3 kinase activation, adjuvant-induced cell death and the release of endogenous danger signals. Expanding our knowledge of alum-induced immunomodulation will greatly enhance our capacity to rationally develop novel adjuvants with specific properties.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据